Literature DB >> 14750618

Ocular manifestations of Behcet's disease in Indian patients.

Jolly Rohatgi1, Archana Singal.   

Abstract

PURPOSE: To study the prevalence, manifestations and severity of ocular involvement in Indian patients with Behcet's disease.
METHOD: Prospective analysis of all patients of suspected Behcet's disease between 1997 and 2001.
RESULTS: A total of 19 patients were diagnosed to have Behcet's disease. Ocular manifestations were seen in 36% patients. The commonest manifestation was conjunctival ulcer (26.3%), followed by iridocyclitis (10.5%). None of the patients had posterior segment involvement or visual loss. Response to topical corticosteroids was good.
CONCLUSION: The prevalence and severity of ocular lesions in Behcet's disease is relatively low in Indian patients. Conjunctival ulcers was a common finding, which is rarely reported in the world literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14750618

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  5 in total

1.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 2.  Visual aspects of Behçet's disease.

Authors:  Tulay Kansu; Sibel Kadayifcilar
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

3.  Nodular scleritis as the eye manifestation in Behcet's syndrome.

Authors:  Karpagam Damodaran; Parthopratim Dutta Majumder; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2015 Jan-Apr

4.  Spectrum of Behçet's disease in the Indian population.

Authors:  Nishant Sachdev; Nandhini Kapali; Ramandeep Singh; Vishali Gupta; Amod Gupta
Journal:  Int Ophthalmol       Date:  2008-10-21       Impact factor: 2.031

5.  Conjunctival Ulcers in Behcet's Disease and Response to Colchicine.

Authors:  Ishmeet Kaur; Archana Singal; Jolly Rohatgi
Journal:  Indian Dermatol Online J       Date:  2020-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.